The Digital Health sector is still emerging with many different terms and imprecise definitions such as eHealth, mHealth, telecare, telehealth, telemedicine and remote healthcare. Due to new technologies also the development of new drugs (like real world evidence) and the fulfilment of pharmacovigilance obligations might be brought to a new level.

New health technologies and device innovation seek to address the demand for efficient delivery of health services. The role of technology in digital health has been described as the super-convergence of wireless, sensors and devices, genomics, social networking, mobile connectivity, imaging, health information systems, the internet, computing power and data. We are working with clients and innovators, applying our digital technology and life sciences expertise to help businesses commercialise their intellectual property and comply with regulatory requirements in order to bring new products and services to market.

Digital Health is crossing international country borders as it tries to achieve the fundamental economies of scale offered by digital and our international offices are able to answer the inevitable cross-border jurisdictional issues.


Telefonica Alpha

Advised Telefonica Alpha (Barcelona) on a software service and the applicability of both healthcare and medical device regulation.

UK telco

Advised a UK telco on regulatory compliance for a range of proposed 'mhealth' services, including whether the services were healthcare services and/or used medical devices.

Healthcare provider

Advised a digital primary care healthcare provider on EU and UK health and data regulations, preparing global contracting documentation and insurance advice.